Breaking News: MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results

MediPharm Labs Corp. (TSX-V: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, will release its fourth quarter and full year financial results ended December 31, 2018 before markets open on Wednesday, April 3, 2019.

About MediPharm Labs Corp.
Founded in 2015, MediPharm Labs has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for advanced derivative products. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream extraction methodologies and purpose-built facilities to deliver pure, safe and precisely-dosed cannabis products to patients and consumers. MediPharm Labs’ private label program is a high margin business for the Company, whereby it opportunistically procures dry cannabis flower and trim from its numerous product supply partners, to produce proprietary cannabis oil concentrate products for resale globally on a private label basis.

Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.

[popuppress id=”204304″]

2 Comments
  1. Glenn Herbert 3 years ago
    Reply

    interested in seeing the results, cannabis oil has a huge consumer base that is only growing

  2. James Schwarz 3 years ago
    Reply

    When I invested in shopify after ipo each quarter people called for the run to end but they kept getting better and better. @MediPharmLabs is running similar instead of e-commerce it’s oil demand

Leave a Comment